Výsledky vyhledávání - "Wendy E. Owens"

Haemophilia A management with emicizumab: A survey of haematologists in the United States

Autor: Anisha M. Patel, Wendy E. Owens, Kathleen Poulos, Karina Raimundo, Gabriel Wong, Janet Bernard, Janet Powers, Richard H. Ko

Publikováno v: The Journal of Haemophilia Practice. 8:155-182

Background Emicizumab is a bispecific monoclonal antibody approved in the United States (US) for the treatment of people with haemophilia A (PwHA) with or without factor VIII (FVIII) inhibitors. Changes to haematologists’ practices since the approv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63c0ccb07e3e6f52e9ffa59875b25f3c
https://doi.org/10.2478/jhp-2021-0017

Zobrazit plný text záznamu

Reliability and validity of patient-reported outcome instruments in US adults with hemophilia B and caregivers in the B-HERO-S study

Autor: Craig M. Kessler, Tyler W. Buckner, David L. Cooper, Michelle Witkop, Robert F. Sidonio, Wendy E. Owens, Christine Guelcher, Neeraj N. Iyer, Moshe Fridman, David B. Clark

Publikováno v: European Journal of Haematology. 101:781-790

Objective To assess the reliability and validity of six patient-reported outcomes (PRO) instruments for evaluating health-related quality of life in adults with mild-severe hemophilia B and caregivers of children with hemophilia B, including affected

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0827bff0446fa05881d5d6372a34601b
https://doi.org/10.1111/ejh.13168

Zobrazit plný text záznamu

Plný text ve formátu HTML

Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study

Autor: Michael Recht, Wendy E. Owens, Neeraj N. Iyer, Skye Peltier, Mary Jane Frey, Tyler W. Buckner, Susan Hunter, Michelle Rice, Natalia Holot, David L. Cooper, Michelle Witkop, Christopher E. Walsh, Christine Guelcher, David B. Clark, Robert F. Sidonio, Neil Frick, Craig M. Kessler

Publikováno v: European Journal of Haematology. 98:5-17

The Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) initiative was launched in an effort to address specific gaps in the understanding of the psychosocial impact of mild-moderate-severe hemophilia B. The origina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4098992325991225f7526ef95672d0ee
https://doi.org/10.1111/ejh.12854

Zobrazit plný text záznamu

Plný text ve formátu HTML

Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study

Autor: Michelle Witkop, Neeraj N. Iyer, David L. Cooper, Robert F. Sidonio, Christine Guelcher, Wendy E. Owens, David B. Clark, Tyler W. Buckner, Craig M. Kessler, Neil Frick

Publikováno v: European journal of haematology. 100(6)

Introduction Health-related quality of life (HRQoL) is impaired in patients with hemophilia; however, the impact in mild/moderate hemophilia B and affected women is not well characterized. Objective To evaluate factors that affect HRQoL in adults wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68af1c2bd3811e0f2abc9f31b5759624
https://pubmed.ncbi.nlm.nih.gov/29505680

Zobrazit plný text záznamu

Plný text ve formátu HTML

Characterization and Disease Management of Persons with Hemophilia A Treated with Emicizumab: A Survey Study of Hematologists in the US

Autor: Wendy E. Owens, Richard H. Ko, Anisha M. Patel, Janet Powers, Janet Bernard, Kathleen Poulos

Publikováno v: Blood. 134:4941-4941

Introduction Emicizumab (EMI) is a subcutaneously administered, bispecific, humanized monoclonal antibody that bridges activated factor IX (FIXa) and FX to restore the function of missing FVIIIa in persons with hemophilia A (PwHA). It was approved in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd3263b758268813d82e6be242942569
https://doi.org/10.1182/blood-2019-123730

Zobrazit plný text záznamu

Understanding Disease Burden Among Persons with Hemophilia Α without Inhibitors

Autor: Anissa Cyhaniuk, Karina Raimundo, Anisha M. Patel, Wendy E. Owens, Richard H. Ko, Elaine Chan

Publikováno v: Blood. 132:4690-4690

Introduction Previous studies have reported significant disease burden in persons with hemophilia A (PwHA) who develop inhibitors to factor VIII. However, disease burden in PwHA without inhibitors (PwHA-WO) is not well understood across severities. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5d343865655e016fb8b4731448795bf2
https://doi.org/10.1182/blood-2018-99-112121

Zobrazit plný text záznamu

Impact of Mild to Severe Hemophilia B on Quality of Life Including Pain and Functional Abilities in Affected Men/Women and Caregivers of Affected Boys/Girls: Analysis of Patient Reported Outcomes in the Bridging Hemophilia B Experiences Results and Opportunities into Solutions (B-HERO-S) Study

Autor: Robert F. Sidonio, Craig M. Kessler, Wendy E. Owens, Michelle Witkop, Tyler W. Buckner, Neil Frick, David L. Cooper, David B. Clark, Christopher E. Walsh, Neeraj N. Iyer, Christine Guelcher

Publikováno v: Blood. 128:251-251

Introduction: Health-related quality-of-life (HRQoL) is impaired in patients with severe congenital hemophilia due to pain and functional impairment associated with hemophilic arthropathy. The impact of mild or moderate hemophilia on HRQoL and on wom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ccd858931dd9b670354984236e3faf7
https://doi.org/10.1182/blood.v128.22.251.251

Zobrazit plný text záznamu

Conference

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání